ClinicalTrials.gg
Not yet recruitingNCT07951008Updated Nov 20, 2026

AI-powered Childbirth Preparation Training

An interventional study of Childbirth preparation education will be provided through an AI-powered mobile application. in Increase in Natural Birth Belief and Reduction in Fear of Childbirth, Childbirth-related Anxiety, and Cesarean Deliveries Through AI, sponsored by Pamukkale University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Pamukkale University · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 20, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

This randomized controlled study aims to evaluate the effect of an artificial intelligence (AI)-supported mobile childbirth preparation program on birth beliefs, childbirth-related worries, fear of childbirth, and mode of delivery in primigravid women.

High rates of planned cesarean section are associated with fear of childbirth, negative birth beliefs, and insufficient prenatal preparation. This study investigates whether a personalized, AI-supported digital education model can improve psychological outcomes and reduce planned cesarean preference.

Study Design

Single-blind, pretest-posttest randomized controlled trial. Participants (primigravid women at 28-32 weeks of gestation) will be randomly assigned to:

Intervention Group: AI-supported mobile childbirth preparation education Control Group: Standard antenatal care only Primary outcomes include changes in birth beliefs, childbirth-related worries, and fear of childbirth.

Secondary outcome is mode of delivery (vaginal birth vs. planned cesarean). Eligibility Criteria (Key Inclusion) Age ≥18 years Primigravid 28-32 weeks of gestation No high-risk pregnancy Access to a mobile device Ethical Approval Ethical approval has been obtained from the Pamukkale University Non-Interventional Clinical Research Ethics Committee (29 July 2025, No: 14).

02

Conditions studied

  • Increase in Natural Birth Belief and Reduction in Fear of Childbirth, Childbirth-related Anxiety, and Cesarean Deliveries Through AI

Keywords

  • Chilbirth Preparation Education
  • Artificial İntelligence-Supported Mobile Application
  • Birth Beliefs
  • Birth worries
  • birth fears
03

In context

Lead sponsor

Pamukkale University is the lead sponsor of 343 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Primigravid pregnant women receiving antenatal care at the Pregnancy Outpatient Clinic of Pamukkale University Hospital.
  • Aged 18 years or older.
  • Completed at least primary school education.
  • Between 28 and 32 weeks of gestation.
  • Have access to a mobile device capable of running the study application.
  • Have not received childbirth preparation education other than standard antenatal care.

Exclusion criteria

Exclusion Criteria:

  • High-risk pregnancy,
  • Including gestational diabetes mellitus,
  • Including gestational hypertension,
  • Including threatened preterm labor, or other pregnancy-related complications.
  • Diagnosis of a psychiatric disorder.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    Childbirth preparation training will be provided through an AI-powered mobile application.

    Other: Childbirth preparation education will be provided through an AI-powered mobile application.

  • No intervention
    Control group

Interventions

  • OtherChildbirth preparation education will be provided through an AI-powered mobile application.

    This intervention is a form of individualized education using artificial intelligence.

    Also known as: Childbirth education

06

What researchers measure

Primary outcomes

  1. Change From Baseline in Natural Process Beliefs as Measured by the Childbirth Beliefs Scale

    Natural process beliefs about childbirth will be measured using the five-item Natural Process subscale of the Childbirth Beliefs Scale. The subscale score is calculated as the mean of the five item scores, with possible scores ranging from 1 to 5. Higher scores indicate stronger beliefs that childbirth is a natural process. The outcome will be reported as the change in mean subscale score from baseline to post-intervention.

    Time frame: 4 weeks

  2. Change From Baseline in Medical Process Beliefs as Measured by the Childbirth Beliefs Scale

    Medical process beliefs about childbirth will be measured using the six-item Medical Process subscale of the Childbirth Beliefs Scale. The subscale score is calculated as the mean of the six item scores, with possible scores ranging from 1 to 5. Higher scores indicate stronger beliefs that childbirth is a medical process. The outcome will be reported as the change in mean subscale score from baseline to post-intervention.

    Time frame: 4 Weeks

  3. Change From Baseline in Childbirth Concern Scores as Measured by the Oxford Worries about Labour Scale

    Childbirth-related concerns will be measured using the 10-item Oxford Worries about Labour Scale. Each item is scored on a four-point Likert scale, producing a total score ranging from 10 to 40. Higher scores indicate lower levels of childbirth-related concern. The outcome will be reported as the change in total scale score from baseline to post-intervention.

    Time frame: 4 weeks

  4. Change From Baseline in Fear of Childbirth Scores as Measured by the Fear of Birth Scale (FOBS)

    Fear of childbirth will be measured using the Fear of Birth Scale (FOBS), a two-item visual analog scale developed by Haines et al. (2011) and validated in Turkish by Serçekuş et al. (2020). Participants indicate their feelings about the upcoming birth on two 100-mm visual analog scales assessing calmness versus worry and no fear versus severe fear. Higher scores indicate greater fear of childbirth. The outcome will be reported as the change in FOBS score from baseline to post-intervention.

    Time frame: 4 weeks

  5. Number of Participants by Mode of Delivery (Vaginal Delivery or Cesarean Section)

    Mode of delivery will be classified into two categories: vaginal delivery and cesarean section. Data will be obtained from obstetric records following childbirth. The number and percentage of participants who undergo vaginal delivery or cesarean section will be reported separately for the intervention and control groups.

    Time frame: At childbirth (up to approximately 16 weeks after enrollment)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — INFORMATION WILL BE SHARED IF THERE IS AN ETHICALLY REASONABLE REQUEST.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Feb 2027, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 17, 2026
First posted
Nov 20, 2026
StartEst.
Nov 17, 2026
Primary completionEst.
Feb 28, 2027
CompletionEst.
May 31, 2027
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07951008
Responsible party
Sevgi Özkan (Prof. Dr., Pamukkale University) — Principal investigator
First posted
Nov 20, 2026
Start date
Nov 17, 2026 (estimated)
Primary completion
Feb 28, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Nov 20, 2026

Study contacts

Sevgi Ö Prof. Dr. Sevgi ÖZKAN, Prof. Dr.
Contact
sozkan@hotmail.com
+9002582964306
Dicle F Yıldırım Gökşen, PhD Student
Contact
diclefiliz.35@gmail.com
+905438355154

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion